按首字母搜索

Cas号索引 2

• 2222755-14-6 | LOXO-292 (Catalog# : 192195)LOXO-292 (ARRY-192) is an oral and selective investigational drug in clinical develop
• 292632-98-5 | L685458 (Catalog# : 186156)L685458 is a potent and selective γ -secretase inhibitor.
• 2097002-61-2 | LOXO-195 (Catalog# : 185212)LOXO-195 is a potent and selective TRK inhibitor capable of addressing potential mech
• 2088939-99-3 | LYN-1604 (Catalog# : 18493)LYN-1604 is a novel activator of ULK1, inducing cell death involved in ATF3, RAD21, a
• 226929-39-1 | LB42708 (Catalog# : 18443)LB42708 is a potent, orally active and selective nonpeptidic farnesyltransferase inhi
• 2040291-27-6 | LLY-283 (Catalog# : 184314)LLY-283 is a potent and selective SAM-competitive chemical probe for PRMT5.
• 231277-92-2 | Lapatinib (Catalog# : 17022807)Lapatinib(GW-572016) is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 n
• 27262-47-1 | Levobupivacaine free base (Catalog# : 16123031)Levobupivacaine is a local anaesthetic drug belonging to the amino amide group. It is
• 2070014-90-1 | LY 303511 hydrochloride (Catalog# : 611819)LY303511 Hcl, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhi
• 253863-00-2 | L-778123 hydrochloride (Catalog# : 121805)L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and
• 248281-84-7 | Laquinimod (Catalog# : 121506)Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva.
• 244240-24-2 | LFM-A13 (Catalog# : 52206)Selective Bruton's tyrosine kinase (BTK) inhibitor (IC50 = 2.5 M). Also inhibits poli
• 2991818-13-2 | MGD-28 (Catalog# : 25073)MGD-28 is a potent molecular glue degrader that demonstrates significant in vitro eff
• 2891709-58-1 | MS6105 (Catalog# : 25039)
• 2763252-25-9 | M3554 (Catalog# : 25017)M3554, a novel anti-GD2 antibody drug conjugate.
• 2990506-75-5 | ML353 (Catalog# : 24151)ML353 is a selective ligand of mGlu5 silent allosteric modulator (SAM).
• 2101538-28-5 | 2-MNG (Catalog# : 24129)2-MNG is an inhibitor for melanogenesis with an average IC50 of 49.5μM. 2-MNG alone
• 2630904-45-7 | MRTX1719 (Catalog# : 262401)MRTX1719 is a potent and selective binder to the PRMT5•MTA complex and selectively
• 2326521-71-3 | MRTX849 (Catalog# : 20611)Adagrasib, also known as MRTX849, is a potent, highly selective, oral available KRAS
• 2377352-49-1 | Migoprotafib (Catalog# : 20592)Migoprotafib, also known as GDC-1971 and RLY-1971, is a SHP2 allosteric inhibitor. GD
• 2861190-30-7 | Mtb-IN-2 (Catalog# : 20572)Mtb-IN-2 (compound 10c) is an antimicrobial agent against Mycobacterium tuberculosis
• 2565656-70-2 | muvalaplin (Catalog# : 20528)
• 2747162-85-0 | MCUF-651 (Catalog# : 20470)MCUF-651 is a small molecule guanylyl cyclase A receptor positive allosteric modulato
• 2654743-22-1 | MRTX0902 (Catalog# : 171462)MRTX0902is a potent SOS1 inhibitor which can be used for the therapeutic intervention
• 210113-85-2 | methyl 4-(2-aminoethoxy)benzoate hydrochloride (Catalog# : 20407)
• 235748-94-4 | methyl (3-chloropyrazin-2-yl)acetate (Catalog# : 20395)
• 2385682-18-6 | methyl 3-bromo-4-ethoxy-5-formylbenzoate (Catalog# : 20364)
• 24589-99-9 | Methyl 3-formyl-4-hydroxybenzoate (Catalog# : 20362)
• 2621928-55-8 | MRTX1133 (Catalog# : 20291)MRTX1133 is a potent and selective KRAS G12D inhibitor. MRTX1133 targets the KRAS G12
• 2416417-65-5 | MYF-01-37 (Catalog# : 20261)MYF-01-37 is a novel covalent inhibitor of TEAD targeting Cys380 when incubated with